Sustained Complete Response after Maintenance Therapy with Topotecan and Erlotinib for Recurrent Cervical Cancer with Distant Metastases

Publisher： Karger

E-ISSN： 1662-6575|7|1|97-101

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-01, pp. : 97-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topotecan in the Therapy of Brain Metastases in Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 25-27

Karger

Access to resources Recommend Favorite

Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-08 ,pp. : 390-394

Karger

Access to resources Recommend Favorite

Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-01 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 123-126

Karger

Access to resources Recommend Favorite